InsiderTrades

Form 4 for INSP Inspire Medical Systems, Inc.

Accepted 2022-04-22 00:00:00 ET · period of report 2022-04-18 · accession 0001104659-22-049152 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2022-04-22 2022-04-18 INSP Herbert Timothy P. CEO, Pres, Dir M - OptEx $1.31 +17.4K 22.6K +333% +$22.9K
DM 2022-04-22 2022-04-18 INSP Herbert Timothy P. CEO, Pres, Dir M - OptEx $0.00 -17.4K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-04-18 M A 9,221 $1.47 14,445 I By family trust — — (F1) Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.
2 Common Common Stock 2022-04-18 M A 8,196 $1.14 22,641 I By family trust — — (F1) Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.
3 Derivative Stock Option (Right to Buy) 2022-04-18 M D 9,221 $0.00 0 D $1.47 · — to 2022-05-01 9,221 Common Stock (F6) Following the reported transactions, there are no remaining options held under this grant by the Reporting Person, either directly or indirectly. (F4) The option is fully vested and exercisable. (F5) This option grant was previously reported as having an expiration date of April 30, 2022, which has been revised herein.
4 Derivative Stock Option (Right to Buy) 2022-04-18 M D 8,196 $0.00 0 D $1.14 · — to 2023-09-12 8,196 Common Stock (F6) Following the reported transactions, there are no remaining options held under this grant by the Reporting Person, either directly or indirectly. (F4) The option is fully vested and exercisable.